News

Biopharmaceutical, COVID-19

The last few weeks have undoubtedly been a paradigm shift for many in our community. Whether an educator, parent, student, scientist, or executive - every single member of the NIIMBL community is adapting quickly to new norms in our business, academic, and personal lives in response to the current coronavirus pandemic. As the world is waiting for...

Biomanufacturing, Biopharmaceutical

The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL), a Manufacturing USA institute, announced that the University of Delaware, on behalf of NIIMBL, has entered into a Collaborative Research and Development Agreement (CRADA) with the Food and Drug Administration (FDA). Effective July 15, 2019, the FDA and NIIMBL will...

Bioengineering, Biomanufacturing, Biopharmaceutical

The mission of the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL), a Manufacturing USA institute, is to accelerate biopharmaceutical manufacturing innovation, support the development of standards that enable more efficient and rapid manufacturing capabilities, and educate and train a world-leading biopharmaceutical...

External News

Biomanufacturing, Biopharmaceutical

Biopharmaceutical manufacturing uses living cells to produce therapies that treat diseases like cancer, diabetes, and autoimmune disorders. Manufacturing medicine using biology presents different challenges from the traditional chemical manufacturing processes that stamp out identical pressed pills.

Biomanufacturing processes are hard to control...

SME
Biomanufacturing, Biopharmaceutical

In my capacity as the Chair of the Council of the Manufacturing USA institute directors, I often get asked about trends in U.S. advanced manufacturing. When I receive a question like this, I try to think about advanced manufacturing as broadly as possible — and consider technologies that could stand to benefit most manufacturers, as well as the U.S...

Our Network @ Work